Peer Review History

Original SubmissionJanuary 5, 2025
Decision Letter - Shady Abdel Aleem, Editor

PONE-D-24-60715Evaluation of Flow Control Using PID versus Fuzzy Logic in an Electropneumatic Circuit for Pulmonary Ventilation ApplicationsPLOS ONE

Dear Dr. Molino,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: The manuscript has a potential. However, the authors have to carefully respond to the queries and suggestions raised by the reviewers. 

Please submit your revised manuscript by Apr 10 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Shady H.E. Abdel Aleem, Phd

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse.

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

4. Thank you for stating the following financial disclosure:

“SENACYT Panama.”

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

5. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“The authors would like to acknowledge the support of SENACYT via grant No. APY-NI2022-13.”

We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“SENACYT Panama.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

6. We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files.]

Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis.

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories.

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

Additional Editor Comments:

The authors have to respond carefully to the queries and comments raised by the reviewers.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: -The introduction fails to clearly define the research gap. It is unclear why this specific comparison between PID and -Fuzzy Logic is necessary in the context of pulmonary ventilation.

-The literature review is outdated and does not adequately reference recent advancements in AI-based or adaptive control techniques for ventilation systems.

-The authors do not critically analyze the limitations of previous works; instead, they merely summarize existing studies without highlighting key shortcomings.

-The description of the electropneumatic circuit design is vague and lacks technical details. Important aspects such as system nonlinearities, sensor characteristics, and actuator dynamics are not well-explained.

-The fuzzy logic controller design lacks justification for the chosen membership functions and rule base. It is unclear why specific linguistic rules were selected and how they were optimized.

-The PID tuning parameters are not justified. The authors do not explain whether Ziegler-Nichols, trial-and-error, or any other systematic tuning method was used.

-No real-world validation: The study appears to be purely simulation-based without experimental verification on actual electropneumatic hardware. This severely limits the practical relevance of the results.

Reviewer #2: In this manuscript, the flow control is evaluated for a prototype electro-pneumatic unit for mechanical ventilator applications through the comparison between the testing results of PID and Fuzzy Logic method. Based on the testing data, the accuracy, the settling time and robustness are evaluated to illustrated the merits and the limits of the fuzzy logic and PID controllers. However, this manuscript contains too-many spelling and grammatical errors. The concrete comments are listed as follows.

1. Check for typos and grammatical mistakes throughout the manuscript to improve readability. For example: "Fuzzy Logic" and "fuzzy logic" should be unified, " quasi-experimental" is confused, "were taken" should be unified in the tense, “The main results show that according, the Bland-Altman analysis” is confused, “The purpose of the PID and Fuzzy Logic control in a prototype electro-pneumatic ventilator” is confused, "Equation 1" should be "Equation (1)" , etc.

2. The PID control algorithm is implemented using the Python library, however the determination of the constant parameters of Kp=5.7, Ki=87.3 and Kd=0.05 in this manuscript should be illustrated in detail.

3. Please illustrate the novelty of the control algorithm of PID and fuzzy logic method used in the tasting system, or the innovation of the experimental device and technique.

4. The parameters in Equations are confused, especially for “Z” and “z”, etc.

5. Unit should be added in the Figures and Tables.

6. The article layout is unreasonable. For example: “2.6 Ethical Statement” should not be in the body of the manuscript, “5. Authors contributions” should be after “8. Conclusion”, “6. Conflict of Interest Statement” and “7. Acknowledgments” should be deleted according to the guideline of author in PLOS One.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes:  Dr. Gaurav Dhiman

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Revision 1

Response to Reviewers Comments.

Ms. Ref. No.: PONE-D-24-60715

Title: Evaluation of Flow Control Using PID versus Fuzzy Logic in an Electropneumatic Circuit for Pulmonary Ventilation Applications.

We want to express our sincere gratitude to both reviewers for their thoughtful and constructive comments. Their evaluations were invaluable in helping us identify areas of improvement and refine the manuscript.

To provide precise and structured responses, we have categorized the comments thematically (e.g., Introduction, Methodology, Results, Language, and Format). This approach ensures clarity and alignment between the reviewers' observations and the corresponding revisions. Furthermore,we also improved the quality of the images.

We have addressed each concern carefully and revised the manuscript accordingly. We are confident that the updated version responds thoroughly to the reviewers' suggestions, both in content and in presentation.

Thank you once again for your contributions to strengthening the quality of our work.

Introduction

Reviewer #1

1. The introduction fails to clearly define the research gap. It is unclear why this specific comparison between PID and Fuzzy Logic is necessary in the context of pulmonary ventilation.

We appreciate the reviewer's suggestion and have significantly revised the introduction to define the research gap better. The revised introduction now explicitly states the limitations of conventional PID controllers in handling nonlinear respiratory dynamics, such as changing lung compliance and airflow resistance, which are common challenges in mechanical ventilation.

Furthermore, we highlight that while Fuzzy Logic Control (FLC) has been explored as an alternative, prior comparisons with PID often relied on theoretical models or simulations rather than direct experimental validation under identical test conditions. To address this gap, our study performs a real-world comparative evaluation of both controllers on an electropneumatic ventilator prototype, ensuring a fair and controlled assessment of their performance in regulating flow, handling disturbances, and adapting to variable lung mechanics.

Additionally, we now clarify this comparison's practical significance, particularly in ventilator shortages, where cost-effective, adaptive control strategies are crucial. The inclusion of recent studies on PID tuning, adaptive fuzzy controllers, and hybrid approaches (e.g., [8,10,12,14,15]) strengthens the motivation for this research by demonstrating that while advanced controllers exist, their comparative effectiveness in real ventilator systems remains an open question.

2. The literature review is outdated and does not adequately reference recent advancements in AI-based or adaptive control techniques for ventilation systems.

Thank you for this valuable feedback. We have updated the literature review in the introduction to incorporate recent advancements in AI-driven and adaptive ventilation control. The revised section now includes:

• Adaptive PID and model-based controllers: Studies on dynamic gain-tuning strategies for PID, such as Tyreus-Luyben tuning and auto-tuning algorithms ([17,18,19]).

• Fuzzy-based intelligent controllers: New research on hybrid fuzzy-PID systems and fuzzy inference applied to respiratory mechanics, highlighting their advantages in handling nonlinearities ([10,15,16,20]).

• Machine learning in ventilator control: Acknowledgment of data-driven approaches, including ANFIS (adaptive neuro-fuzzy inference systems) and AI-assisted tuning methods ([13,22,24]).

3. The authors do not critically analyze the limitations of previous works; instead, they merely summarize existing studies without highlighting key shortcomings.

We acknowledge this concern and have strengthened our critical discussion of previous studies in the introduction. The revised text now explicitly identifies three major shortcomings in prior PID vs. fuzzy logic comparisons:

• Lack of direct experimental validation: Many studies on fuzzy logic controllers rely on simulated patient models rather than real electro-pneumatic ventilator implementations, making it difficult to assess real-world applicability ([9,13,15]).

• Limited consideration of dynamic patient conditions: Traditional PID controllers are often evaluated under static lung compliance scenarios, whereas real patients exhibit significant variability that may degrade PID performance over time ([8,17,18]).

• Absence of comprehensive performance metrics: While prior research reports improvements in rise time and overshoot, few studies compare stability margins, steady-state error, and response to disturbances in a single experimental framework ([10,12,14]).

Our study directly addresses these gaps by conducting a controlled experimental comparison of both controllers on an electro-pneumatic ventilator, providing quantitative insights into their performance across multiple ventilation scenarios.

Methodology / Experimental Setup

Reviewer #1

1. The description of the electro-pneumatic circuit design is vague and lacks technical details. Important aspects such as system nonlinearities, sensor characteristics, and actuator dynamics are not well-explained.

We appreciate this observation. In the revised manuscript, we have significantly expanded the description of the electropneumatic system. Specific nonlinearities—such as valve hysteresis, sensor latency, and dynamic compliance/resistance of the test lung—are now explicitly addressed (Section: System Nonlinearities and Dynamic Characteristics). We also added detailed specifications for the sensors (Sensirion SFM3000) and actuators (Camozzi Series AP and CFB) in Table 1 and throughout the system description. This contextualization clarifies the sources of nonlinearity and their control implications.

2. The fuzzy logic controller design lacks justification for the chosen membership functions and rule base. It is unclear why specific linguistic rules were selected and how they were optimized.

We have expanded the explanation of the FLC design to include justification for both the membership functions and the rule base. Triangular membership functions were selected to ensure smooth transitions and computational efficiency. The 25-rule base was constructed to mimic expert respiratory therapy heuristics, using a 5×5 matrix mapping of flow error and error rate. Empirical tuning and system response analysis were employed to refine rule behavior and optimize stability, which is now explained in detail in the section Fuzzy Logic Controller (FLC) Design.

3. The PID tuning parameters are not justified. The authors do not explain whether Ziegler-Nichols, trial-and-error, or any other systematic tuning method was used.

We now clarify that the Ziegler-Nichols method was initially used to determine preliminary gain values (Kc and Tu), followed by empirical fine-tuning to mitigate overshoot and reduce steady-state error. This process is described under PID Controller Design and Tuning, along with the final tuning values (Kp=5.7, Ki=87.3, Kd=0.05). We also added commentary on why the initial Ziegler-Nichols estimates were not directly applied due to system sensitivity.

Reviewer #2

1. The PID control algorithm is implemented using the Python library; however, the determination of the constant parameters of Kp=5.7, Ki=87.3, and Kd=0.05 in this manuscript should be illustrated in detail.

As requested, we now provide a full description of the PID tuning process. The controller was initially tuned using the Ziegler-Nichols method to estimate critical gain and oscillation period, and the resulting gains were refined experimentally. The tuning process was guided by optimizing the response to step inputs, aiming to minimize overshoot and settling time while ensuring stability in the presence of nonlinear actuator and lung dynamics. This clarification is included in the PID Controller Design and Tuning section.

2. Please illustrate the novelty of the control algorithm of PID and fuzzy logic method used in the testing system, or the innovation of the experimental device and technique.

We appreciate the reviewer's observation regarding the novelty of our control algorithms and prototype design. In response, we have expanded the methodology section—particularly under "Experimental Validation"—to explicitly outline the innovative aspects of our system. The revised manuscript now emphasizes the following key contributions:

• Novel experimental setup: Unlike many previous studies that rely solely on simulation, our study presents a fully implemented electropneumatic ventilator prototype using commercial components (e.g., ESP32, Camozzi valves, Sensirion SFM3000 sensor). This allows for real-world evaluation of control strategies under dynamic respiratory conditions.

• Unique comparative framework: Both the PID and fuzzy logic controllers were implemented on the same physical prototype, allowing for a direct, controlled, and empirical comparison. This approach mitigates confounding factors often present in simulation-only or non-parallel studies.

• Controller implementation details: The PID controller was tuned using the Ziegler–Nichols method, followed by fine-tuning to address overshoot and delay under load. The fuzzy controller design uses two trapezoidal-input universes and a 12-rule base optimized for real-time response, implemented via Python and an LUT-based method to address memory limitations of the ESP32.

• Experimental rigor: The system's response was evaluated using step-response, perturbation rejection, and Bland–Altman analysis, offering a detailed empirical performance assessment rarely reported in similar ventilator controller studies.

• Low-cost and scalable design: The controller architecture, based on open-source hardware and libraries, supports replication and potential adaptation for emergency use in resource-constrained environments—a relevant innovation in the context of future pandemics or disaster-response medicine.

These additions are summarized in the newly added "Novelty of the Approach" paragraph within the Methodology section (see end of "Experimental Validation").

Results & Validation

Reviewer #1

1. No real-world validation: The study appears to be purely simulation-based without experimental verification on actual electropneumatic hardware. This severely limits the practical relevance of the results.

We thank the reviewer for this important comment. We respectfully clarify that the ventilator system described in this study is a fully constructed hardware prototype, not a simulation-only model. The experiments were conducted using physical components, including an ESP32 microcontroller, Camozzi Series AP and CFB valves, a Sensirion SFM3000 flow sensor, and a medical-grade Aridyne 3500 air compressor.

Validation was carried out using the ACCU LUNG test lung and VT650 flow and pressure analyzer, both manufactured by Fluke. These devices are industry-standard tools for verifying respiratory device performance under safe, repeatable, and clinically relevant simulated conditions. They enable the evaluation of control system behavior under variable compliance and resistance settings without the ethical and logistical complexities of patient testing.

We agree that clinical trials represent the next stage in ventilator development; however, our current objective is to provide a robust technical comparison of PID and Fuzzy Logic control strategies within a validated physical testbed. This approach aligns with standard ventilator development workflows and supports early-stage innovation, especially in the context of cost-effective, locally manufactured solutions.

Clarity & Language

Reviewer #2:

1. Check for typos and grammatical mistakes throughout the manuscript to improve readability. For example: 'Fuzzy Logic' and 'fuzzy logic' should be unified, 'quasi-experimental' is confused, 'were taken' should be unified in the tense, 'The main results show that according, the Bland-Altman analysis' is confused, 'The purpose of the PID and Fuzzy Logic control in a prototype electro-pneumatic ventilator' is confused, 'Equation 1' should be 'Equation (1)', etc.

We appreciate the reviewer's detailed feedback. A comprehensive grammatical and stylistic revision was performed throughout the manuscript. We believe we have addressed all the shortcomings in the style, specifically:

• Capitalization: Fuzzy Logic is consistently capitalized throughout the text to ensure uniformity and professionalism.

• Clarification of Study Design: The term quasi-experimental was removed from the Abstract to avoid ambiguity. It now reads:

A laboratory-based experimental study was conducted under laboratory conditions, using a test lung simulator and real-time flow data acquisition.

• Equation references were standardized in accordance with journal guidelines (e.g., "Equation (1)").

• Units have been added or clarified in figures and tables as needed.

2. The parameters in Equations are confused, especially for 'Z' and 'z', etc." "In Equations (2) and (3), the variable z denotes the complex frequency domain variable used in Z-transform analysis for discrete-time systems.

We thank the reviewer for this observation. To prevent confusion between the uses of the symbols 'Z' and 'z', we have clarified their meaning explicitly in the revised manuscript.

In the Repeatability section, the variable 'Z' refers to the critical value from the standard normal distribution used in the sample size estimation formula. We added the following sentence to clarify this usage:

Here, Z represents the critical value of the standard normal distribution corresponding to the desired confidence level.

In the Jury Analysis section, the variable 'z' denotes the Z-domain variable commonly used in transfer function representation for discrete-time systems. We clarified this by adding the sentence:

In Equations (2) and (3), the variable z denotes the complex frequency domain variable used in Z-transform analysis for discrete-time systems.

3. Unit should be added in the Figures and Tables.

We have revised all figures and tables to indicate appropriate units clearly.

• For example, in Table 2 (PID tuning parameters) and Table 4 (Fisher test values), all variables now include units where applicable (e.g., flow in L/min, pressure in psi or bar, time in seconds, etc.).

• In the Bland–Altman results (Table 2) and associated plots (Figure 2), units such as liters per minute (L/min) have been specified for clarity and consistency.

• Additionally, y-axis and x-axis labels and style in all plots and figures were reviewed and updated to reflect proper units and a homogeneus visuals.

Structure & Formatting Issues

Reviewer #2:

1. The article layout is unreasonable. For example: '2.6 Ethical Statement' should not be in the body of the manuscript, '5. Authors contributions' should be after '8. Conclusion', '6. Conflict of Interest Statement' and '7. Acknowledgments' should be deleted according to the guideline of author in PLOS One.

We thank the reviewer for the helpful observations regarding the manuscript structure. The article layout has been revised to comply with the journal's formatting guidelines. All required sections have been repositioned or removed as appropriate, ensuring consistency with PLOS ONE's submission standards. We appreciate the reviewer's input in helping us improve the clarity and organization of the manuscript.

Attachments
Attachment
Submitted filename: ResponseReviewersComments_22032025.docx
Decision Letter - Shady Abdel Aleem, Editor

Evaluation of Flow Control Using PID versus Fuzzy Logic in an Electropneumatic Circuit for Pulmonary Ventilation Applications

PONE-D-24-60715R1

Dear Dr. Molino,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Shady H.E. Abdel Aleem, Phd

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I accept this work. I accept this work. I accept this work. I accept this work. I accept this work. I accept this work.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Shady Abdel Aleem, Editor

PONE-D-24-60715R1

PLOS ONE

Dear Dr. Molino,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Shady H.E. Abdel Aleem

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .